Form D · Other
BioLite, Inc.
Brooklyn, NY · CIK 0002028985
Offering snapshot reported Mar 3, 2025 · SEC filing
- Reported sold
- $4M Offering amount: $6M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 18, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 3, 2025 | Initial | $4,000,000 | No comparison | 2 | SEC filing |
| Jul 2, 2024 | Initial | $400,000 | No comparison | 2 | SEC filing |
| Jul 2, 2024 | Initial | $6,497,898 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-539687
Convertible Promissory Note, and the Equity Securities Issuable upon conversion of such Convertible Promissory Note.
Source: Form D, filed Mar 3, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jonathan Cedar | Director, Executive |
| Matthew Christensen | Director |
| Robb Dahir | Executive |
| Derek Ewald | Executive |
| Lyndsay Handler | Director |
| Katherine Hill | Director |
| Amar Inamdar | Director |
Issuer details
Industry: Other (See others in industry)
Address:
65 Jay Street, Floor 4
Brooklyn, NY, 11201
Brooklyn, NY, 11201